Boston Scientific Net Income 2006-2018 | BSX

Boston Scientific annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Boston Scientific net income for the quarter ending September 30, 2018 was $0.432B, a 52.65% increase year-over-year.
  • Boston Scientific net income for the twelve months ending September 30, 2018 was $670M, a 20.52% decline year-over-year.
  • Boston Scientific annual net income for 2017 was $0.104B, a 70.03% decline from 2016.
  • Boston Scientific annual net income for 2016 was $0.347B, a 245.19% decline from 2015.
  • Boston Scientific annual net income for 2015 was $-0.239B, a 100.84% increase from 2014.
Boston Scientific Annual Net Income
(Millions of US $)
2017 $104
2016 $347
2015 $-239
2014 $-119
2013 $-121
2012 $-4,068
2011 $441
2010 $-1,065
2009 $-1,025
2008 $-2,036
2007 $-495
2006 $-3,577
2005 $628
Boston Scientific Quarterly Net Income
(Millions of US $)
Q3 2018 $432
Q2 2018 $555
Q1 2018 $298
Q4 2017 $-615
Q3 2017 $283
Q2 2017 $146
Q1 2017 $290
Q4 2016 $124
Q3 2016 $228
Q2 2016 $-207
Q1 2016 $202
Q4 2015 $-142
Q3 2015 $-198
Q2 2015 $102
Q1 2015 $-1
Q4 2014 $-299
Q3 2014 $43
Q2 2014 $4
Q1 2014 $133
Q4 2013 $108
Q3 2013 $-5
Q2 2013 $130
Q1 2013 $-354
Q4 2012 $61
Q3 2012 $-664
Q2 2012 $-3,578
Q1 2012 $113
Q4 2011 $107
Q3 2011 $142
Q2 2011 $146
Q1 2011 $46
Q4 2010 $236
Q3 2010 $190
Q2 2010 $98
Q1 2010 $-1,589
Q4 2009 $-1,076
Q3 2009 $-94
Q2 2009 $158
Q1 2009 $-13
Q4 2008 $-2,382
Q3 2008 $-74
Q2 2008 $98
Q1 2008 $322
Q4 2007 $-458
Q3 2007 $-272
Q2 2007 $115
Q1 2007 $120
Q4 2006 $277
Q3 2006 $76
Q2 2006 $-4,262
Q1 2006 $332
Q4 2005 $334
Q3 2005 $-269
Q2 2005 $205
Q1 2005 $358
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.540B $9.048B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $125.870B 18.82
Abbott Laboratories (ABT) United States $124.278B 25.18
Stryker (SYK) United States $62.325B 23.49
Baxter (BAX) United States $34.962B 22.58
Zimmer Biomet Holdings (ZBH) United States $22.231B 14.42
Smith & Nephew SNATS (SNN) United Kingdom $16.467B 0.00
ResMed (RMD) United States $16.093B 30.69
Perrigo (PRGO) Ireland $7.742B 11.75
Bio-Rad Laboratories (BIO) United States $7.425B 47.47
Canopy Growth (CGC) Canada $7.178B 0.00
Hill-Rom Holdings (HRC) United States $6.230B 19.49
Aurora Cannabis (ACB) Canada $5.840B 30.84
Haemonetics (HAE) United States $5.316B 46.75
Insulet (PODD) United States $4.707B 0.00
ICU Medical (ICUI) United States $4.538B 25.28
Hutchison China MediTech (HCM) China $4.506B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.605B 0.00
Neogen (NEOG) United States $3.236B 49.00
Agios Pharmaceuticals (AGIO) United States $2.998B 0.00
NuVasive (NUVA) United States $2.834B 26.37
National Vision Holdings (EYE) United States $2.303B 44.54
Quidel (QDEL) United States $1.963B 25.59
NxStage Medical (NXTM) United States $1.895B 0.00
Aphria (APHA) $1.399B 0.00
Phibro Animal Health (PAHC) United States $1.330B 18.83
AtriCure (ATRC) United States $1.135B 0.00
Cardiovascular Systems (CSII) United States $0.971B 1397.50
VAREX IMAGING (VREX) United States $0.893B 17.88
PetIQ (PETQ) United States $0.841B 21.79
Cerus (CERS) United States $0.750B 0.00
Meridian Bioscience (VIVO) United States $0.741B 23.61
Surmodics (SRDX) United States $0.740B 112.69
OraSure Technologies (OSUR) United States $0.701B 39.48
Lantheus Holdings (LNTH) United States $0.665B 20.58
Eagle Pharmaceuticals (EGRX) United States $0.655B 21.02
Omeros (OMER) United States $0.651B 0.00
MacroGenics (MGNX) United States $0.579B 0.00
NanoString Technologies (NSTG) United States $0.506B 0.00
LeMaitre Vascular (LMAT) United States $0.488B 23.95
Quanterix (QTRX) United States $0.409B 0.00
Owens & Minor (OMI) United States $0.402B 4.55
TG Therapeutics (TGTX) United States $0.394B 0.00
Insys Therapeutics (INSY) United States $0.365B 0.00
Evolus (EOLS) United States $0.345B 0.00
Utah Medical Products (UTMD) United States $0.317B 20.51
VAPOTHERM INC (VAPO) United States $0.303B 0.00
Cytosorbents (CTSO) United States $0.287B 0.00
Surface Oncology (SURF) United States $0.228B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.225B 0.00
BioLife Solutions (BLFS) United States $0.205B 277.25
Rockwell Medical (RMTI) United States $0.179B 0.00
Chimerix (CMRX) United States $0.165B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.136B 0.00
Fonar (FONR) United States $0.134B 6.75
Chembio Diagnostics (CEMI) United States $0.103B 0.00
Female Health (VERU) United States $0.085B 0.00
United-Guardian (UG) United States $0.079B 16.63
Oramed Pharmaceuticals (ORMP) United States $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 17.27
CAS Medical Systems (CASM) United States $0.050B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Neurotrope (NTRP) United States $0.032B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.017B 0.00
Capricor Therapeutics (CAPR) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Senestech (SNES) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00